The Asia-Pacific CRISPR market is anticipated to record a CAGR of 21.18% over the estimated years of 2021 to 2028. The regional market’s growth is credited to key factors such as the rising dependency of consumers on non-vegetarian foods such as poultry meat, red meat, and seafood, the presence of well-recognized agriculture research facilities for developing productive and effective crops, and increased research and development (R&D) activities implemented in emerging economies.

ASIA-PACIFIC CRISPR MARKET FORECAST 2021-2028

Asia Pacific CRISPR Market by Product (Plasmids, Vectors, Proteins, Designing Tools, Grna, Control Kits, Library, Other Products) Market by Application (Genome Editing/genetic Engineering, CRISPR Plasmid, Human Stem Cells, Grna Database/gene Library, Cell Line Engineering) Market by End-user (Therapeutics and Drug Discovery, Biological Research, Agricultural Biotech, Industrial Biotech) by Geography

Request free sample

The Asia-Pacific CRISPR market is anticipated to record a CAGR of 21.18% over the estimated years of 2021 to 2028. The regional market’s growth is credited to key factors such as the rising dependency of consumers on non-vegetarian foods such as poultry meat, red meat, and seafood, the presence of well-recognized agriculture research facilities for developing productive and effective crops, and increased research and development (R&D) activities implemented in emerging economies.asia-pacific-crispr-market

To learn more about this report, request a free sample copy

The Asia-Pacific CRISPR market growth study entails the assessment of India, Singapore, Malaysia, South Korea, Thailand, Australia & New Zealand, China, Japan, and the rest of the Asia-Pacific. Japan continues to witness substantial growth in terms of innovation within CRISPR technology. For instance, in 2021, Sanatech Seed launched the foremost direct consumption genome-edited tomato in the country. However, in this regard, the Japanese ministries in charge announced that the genome-edited tomato would not be regulated as a genetically modified product.

On the other hand, new research on CRISPR is set to propel market growth in India. In 2019, for example, the country’s scientists developed a novel variant of the presently popular gene-editing tool, CRISPR-Cas9. The variant has the potential to increase precision in editing the genome while evading unintended DNA changes. Thus, these factors are set to influence the CRISPR market in the Asia-Pacific during the forecasted years.

Intellia Therapeutics, headquartered in the United States, is a genome editing company involved in developing exclusive, potentially curative therapeutics utilizing the recent biological tool termed CRISPR/Cas9 system. The combination of extensive clinical development experience and profound scientific expertise places the company in a unique position to unravel broad therapeutic applications of the CRISPR/Cas9 technology.

 

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

 

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • RISK OF CONGENITAL ANOMALIES
        • PREVALENCE OF GENETIC DISORDERS
        • GROWING USE OF CRISPR IN AGRICULTURE
        • RISING AWARENESS REGARDING GENE THERAPEUTICS
      • KEY RESTRAINTS
        • POSSIBLE MISUSE OF CRISPR GENE-EDITING TOOL
        • LACK OF HEALTHCARE BUDGETS IN DEVELOPING COUNTRIES
        • ETHICAL ISSUES
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON CRISPR MARKET
      • PATENT ANALYSIS
      • FUNDING SCENARIO
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • KEY BUYING CRITERIA
        • COST
        • ACCURACY
        • EASY TO USE
      • LEGAL & REGULATORY FRAMEWORK
    2. MARKET BY PRODUCT
      • PLASMIDS
      • VECTORS
      • PROTEINS
      • DESIGNING TOOLS
      • GRNA
      • CONTROL KITS
      • LIBRARY
      • OTHER PRODUCTS
    3. MARKET BY APPLICATION
      • GENOME EDITING/GENETIC ENGINEERING
      • CRISPR PLASMID
      • HUMAN STEM CELLS
      • GRNA DATABASE/GENE LIBRARY
      • CELL LINE ENGINEERING
    4. MARKET BY END-USER
      • THERAPEUTICS AND DRUG DISCOVERY
      • BIOLOGICAL RESEARCH
      • AGRICULTURAL BIOTECH
      • INDUSTRIAL BIOTECH
    5. GEOGRAPHICAL ANALYSIS
      • ASIA-PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • INDIA
          • SOUTH KOREA
          • SINGAPORE
          • THAILAND
          • MALAYSIA
          • AUSTRALIA & NEW ZEALAND
          • REST OF ASIA-PACIFIC
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS & DIVESTITURES
      • COMPANY PROFILES
        • ADDGENE
        • CARIBOU BIOSCIENCES INC
        • CELLECTIS BIORESEARCH SAS
        • CRISPR THERAPEUTICS AG
        • EDITAS MEDICINE
        • GENSCRIPT
        • HORIZON DISCOVERY GROUP
        • INTEGRATED DNA TECHNOLOGIES
        • INTELLIA THERAPEUTICS
        • LONZA GROUP LTD
        • NEW ENGLAND BIOLABS
        • NOVARTIS INTERNATIONAL AG
        • ORIGENE TECHNOLOGIES INC
        • PRECISION BIOSCIENCES
        • SYNTHEGO CORPORATION
        • THERMO FISHER SCIENTIFIC INC

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – CRISPR

    TABLE 2: FUNDING SCENARIO OF PUBLIC COMPANIES

    TABLE 3: FUNDING SCENARIO OF PRIVATE COMPANIES

    TABLE 4: FUNDING SCENARIO OF GOVERNMENT ORGANIZATIONS

    TABLE 5: REGULATORY FRAMEWORK

    TABLE 6: ASIA-PACIFIC CRISPR MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: ASIA-PACIFIC CRISPR MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 8: ASIA-PACIFIC CRISPR MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: ASIA-PACIFIC CRISPR MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 10: ASIA-PACIFIC CRISPR MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 11: ASIA-PACIFIC CRISPR MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 12: ASIA-PACIFIC CRISPR MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 13: ASIA-PACIFIC CRISPR MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 14: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CRISPR MARKET

    TABLE 15: LIST OF MERGERS & ACQUISITIONS

    TABLE 16: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 17: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 18: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

    LIST OF FIGURES

    FIGURE 1: FUNDING SCENARIO SHARE, BY TYPE OF COMPANIES/ORGANIZATION

    FIGURE 2: KEY MARKET TRENDS

    FIGURE 3: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 4: OPPORTUNITY MATRIX

    FIGURE 5: VENDOR LANDSCAPE

    FIGURE 6: KEY BUYING CRITERIA

    FIGURE 7: ASIA-PACIFIC CRISPR MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2020

    FIGURE 8: ASIA-PACIFIC CRISPR MARKET, BY PLASMIDS, 2021-2028 (IN $ MILLION)

    FIGURE 9: ASIA-PACIFIC CRISPR MARKET, BY VECTORS, 2021-2028 (IN $ MILLION)

    FIGURE 10: ASIA-PACIFIC CRISPR MARKET, BY PROTEINS, 2021-2028 (IN $ MILLION)

    FIGURE 11: ASIA-PACIFIC CRISPR MARKET, BY DESIGNING TOOLS, 2021-2028 (IN $ MILLION)

    FIGURE 12: ASIA-PACIFIC CRISPR MARKET, BY GRNA, 2021-2028 (IN $ MILLION)

    FIGURE 13: ASIA-PACIFIC CRISPR MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)

    FIGURE 14: ASIA-PACIFIC CRISPR MARKET, BY LIBRARY, 2021-2028 (IN $ MILLION)

    FIGURE 15: ASIA-PACIFIC CRISPR MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)

    FIGURE 16: ASIA-PACIFIC CRISPR MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2020

    FIGURE 17: ASIA-PACIFIC CRISPR MARKET, BY GENOME EDITING/GENETIC ENGINEERING, 2021-2028 (IN $ MILLION)

    FIGURE 18: ASIA-PACIFIC CRISPR MARKET, BY CRISPR PLASMID, 2021-2028 (IN $ MILLION)

    FIGURE 19: ASIA-PACIFIC CRISPR MARKET, BY HUMAN STEM CELLS, 2021-2028 (IN $ MILLION)

    FIGURE 20: ASIA-PACIFIC CRISPR MARKET, BY GRNA DATABASE/GENE LIBRARY, 2021-2028 (IN $ MILLION)

    FIGURE 21: ASIA-PACIFIC CRISPR MARKET, BY CELL LINE ENGINEERING, 2021-2028 (IN $ MILLION)

    FIGURE 22: ASIA-PACIFIC CRISPR MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020

    FIGURE 23: ASIA-PACIFIC CRISPR MARKET, BY THERAPEUTICS AND DRUGS DISCOVERY, 2021-2028 (IN $ MILLION)

    FIGURE 24: ASIA-PACIFIC CRISPR MARKET, BY BIOLOGICAL RESEARCH, 2021-2028 (IN $ MILLION)

    FIGURE 25: ASIA-PACIFIC CRISPR MARKET, BY AGRICULTURAL BIOTECH, 2021-2028 (IN $ MILLION)

    FIGURE 26: ASIA-PACIFIC CRISPR MARKET, BY INDUSTRIAL BIOTECH, 2021-2028 (IN $ MILLION)

    FIGURE 27: ASIA-PACIFIC CRISPR MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 28: CHINA CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 29: JAPAN CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 30: INDIA CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 31: SOUTH KOREA CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 32: SINGAPORE CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 33: THAILAND CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 34: MALAYSIA CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 35: AUSTRALIA & NEW ZEALAND CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 36: REST OF ASIA-PACIFIC CRISPR MARKET, 2021-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      • ASIA-PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • INDIA
          • SOUTH KOREA
          • SINGAPORE
          • THAILAND
          • MALAYSIA
          • AUSTRALIA & NEW ZEALAND
          • REST OF ASIA-PACIFIC
    1. MARKET BY PRODUCT
      • PLASMIDS
      • VECTORS
      • PROTEINS
      • DESIGNING TOOLS
      • GRNA
      • CONTROL KITS
      • LIBRARY
      • OTHER PRODUCTS
    2. MARKET BY APPLICATION
      • GENOME EDITING/GENETIC ENGINEERING
      • CRISPR PLASMID
      • HUMAN STEM CELLS
      • GRNA DATABASE/GENE LIBRARY
      • CELL LINE ENGINEERING
    3. MARKET BY END-USER
      • THERAPEUTICS AND DRUG DISCOVERY
      • BIOLOGICAL RESEARCH
      • AGRICULTURAL BIOTECH
      • INDUSTRIAL BIOTECH

     

    To request a free sample copy of this report, please complete the form below :
    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type